Whats new
Whats new.
Maxim Group: Efti+Keytruda Leads to Positive Survival Data in 1L Lung Cancer; Raise tgt to $10, mtn Buy (Jason McCarthy, PhD)
May 17th 2023
For a copy of this analyst report please contact your Maxim advisor
Whats new
May 17th 2023
For a copy of this analyst report please contact your Maxim advisor